Neurodegenerative Conditions

Disease

Related News

CNS Biomarkers, Amyloid Beta Therapeutics, and Calcineurin Inhibitors Markets: Growth Projections to 2035

May 26, 2026

The global CNS biomarkers market is projected to reach USD 26.13 billion by 2035, amyloid beta therapeutics USD 26.50 billion, and calcineurin inhibitors USD 20.88 billion. AI integration is driving innovation across all three markets.

Tozaro Secures £6 Million to Reduce Gene Therapy Manufacturing Costs

Feb 16, 2026

Tozaro, a Bedfordshire-based biotech company, has raised £6 million in funding led by Mercia Ventures to advance its Smart Polymer technology aimed at reducing the high production costs of cell and gene therapies.